234 related articles for article (PubMed ID: 24780467)
21. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
Huang WH; Hung CC; Yang CW; Huang JY
Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
[TBL] [Abstract][Full Text] [Related]
22. Removal of protein-bound uraemic toxins by haemodialysis.
Niwa T
Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
[TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
Watanabe H
Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
[TBL] [Abstract][Full Text] [Related]
24. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
[TBL] [Abstract][Full Text] [Related]
25. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
26. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.
Vanholder R; Schepers E; Pletinck A; Nagler EV; Glorieux G
J Am Soc Nephrol; 2014 Sep; 25(9):1897-907. PubMed ID: 24812165
[TBL] [Abstract][Full Text] [Related]
27. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
[TBL] [Abstract][Full Text] [Related]
28. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.
de Loor H; Meijers BK; Meyer TW; Bammens B; Verbeke K; Dehaen W; Evenepoel P
J Chromatogr A; 2009 May; 1216(22):4684-8. PubMed ID: 19394619
[TBL] [Abstract][Full Text] [Related]
29. Protein-Bound Uremic Toxins and Immunity.
Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
[TBL] [Abstract][Full Text] [Related]
30. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
Mutsaers HA; Caetano-Pinto P; Seegers AE; Dankers AC; van den Broek PH; Wetzels JF; van den Brand JA; van den Heuvel LP; Hoenderop JG; Wilmer MJ; Masereeuw R
Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
[TBL] [Abstract][Full Text] [Related]
31. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
32. The removal of protein-bound solutes by dialysis.
Meyer TW
J Ren Nutr; 2012 Jan; 22(1):203-6. PubMed ID: 22200443
[TBL] [Abstract][Full Text] [Related]
33. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
34. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
35. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
36. Update of uremic toxin research by mass spectrometry.
Niwa T
Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
[TBL] [Abstract][Full Text] [Related]
37. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate.
Opdebeeck B; D'Haese PC; Verhulst A
Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963891
[TBL] [Abstract][Full Text] [Related]
38. An update on protein-bound uremic retention solutes.
Vanholder R; Schepers E; Pletinck A; Neirynck N; Glorieux G
J Ren Nutr; 2012 Jan; 22(1):90-4. PubMed ID: 22200422
[TBL] [Abstract][Full Text] [Related]
39. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.
Gryp T; Huys GRB; Joossens M; Van Biesen W; Glorieux G; Vaneechoutte M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183306
[TBL] [Abstract][Full Text] [Related]
40. Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?
Liabeuf S; Villain C; Massy ZA
Clin Sci (Lond); 2016 Dec; 130(23):2209-2216. PubMed ID: 27799624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
